Before ECP
How is Renew™ ECP Therapy performed?
At Renew™, your journey begins with a thorough assessment by our expert team, followed by therapy delivered by a trained Renew™ ECP Therapist.
Here’s how it works:
- Compression cuffs are wrapped around your calves, thighs, and hips.
- ECG sensors and a fingertip device sync the cuff movements with your heartbeat.
- The cuffs inflate and deflate in rhythm, boosting blood flow from your legs to your heart.
This process encourages the formation of “natural bypasses” around blocked arteries, improving circulation and transforming your overall health.
Experience the Renew™ difference and feel the results!
During ECP
What to Expect During Renew™ ECP Therapy
Four step ECP Therapy process
The cuffs inflate sequentially from calves to hips, pushing blood toward the heart to improve circulation. This rhythmic, massage-like pressure boosts oxygenated blood flow, opens collateral arteries, and reduces the heart’s workload. It enhances diastolic pressure, supporting cardiovascular health and other organ functions.
Contraindications
Who is Renew™ ECP Therapy for?
Renew™ ECP Therapy is NOT suitable for individuals with the following conditions
- Any surgical intervention within six weeks before ECP treatment.
- Cardiac catheterisation within one to two weeks before ECP treatment.
- Uncontrolled arrhythmia or controlled arrhythmias that could interfere with ECP inflation and deflation triggering.
- Dual chamber pacemakers where atrial pacing may interfere with ECP inflation timing sequence. This should be addressed prior to treatment.
- Aortic insufficiency (regurgitation can prevent diastolic augmentation).
- Severe pulmonary disease.
- Limiting peripheral vascular disease involving the ileofemoral arteries.
- Deep-vein thrombophlebitis (risk of thromboembolus).
- Severe hypertension (≥ 180 mmHg systolic or ≥110 mmHg diastolic).
- Bleeding disorders.
- Patients undergoing major anti-coagulation therapy (such as Heparin therapy or Coumadin® therapy) with PT > 1.5.
COUMADIN® is a registered trademark of Bristol-Myers Squibb Pharma Company - Heart rates less than 35 or more than 125 beats per minute (Patients with these heart rates should be evaluated and treated prior to ECP treatments).
- Presence of local infection, vasculitis of the extremities, or abdominal aortic aneurysm.
- Pregnant women and women of childbearing age who do not have a negative pregnancy test.
- Presence of a burn, open wound, or bone fracture on any limb subject to ECP treatment.
